| 12.45 -0.81 (-6.11%) | 04-21 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 15.79 | 1-year : | 18.44 |
| Resists | First : | 13.52 | Second : | 15.79 |
| Pivot price | 11.6  |
|||
| Supports | First : | 10.59 | Second : | 8.78 |
| MAs | MA(5) : | 12.73 |
MA(20) : | 11.09 |
| MA(100) : | 11.79 |
MA(250) : | 8.78 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 89.9 |
D(3) : | 95.4 |
| RSI | RSI(14): 58.5 |
|||
| 52-week | High : | 13.65 | Low : | 4.62 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PILL ] has closed below upper band by 28.6%. Bollinger Bands are 60% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 12.94 - 13.01 | 13.01 - 13.07 |
| Low: | 12.11 - 12.2 | 12.2 - 12.27 |
| Close: | 12.32 - 12.45 | 12.45 - 12.56 |
The Direxion Daily Pharmaceutical & Medical Bull 3X ETF seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Pharmaceuticals Select Industry Index. There is no guarantee the fund will achieve its stated investment objective.
Sat, 11 Apr 2026
Avoiding Lag: Real-Time Signals in (PILL) Movement - Stock Traders Daily
Tue, 31 Mar 2026
Discipline and Rules-Based Execution in PILL Response - Stock Traders Daily
Tue, 10 Feb 2026
5 Small-cap Biotech ETFs to Watch - Investing News Network
Mon, 26 Jan 2026
Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026? - Barchart.com
Fri, 16 Jan 2026
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 - 24/7 Wall St.
Tue, 16 Dec 2025
Top Performing Leveraged/Inverse ETFs: 12/14/2025 - ETF Database
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|